Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chase

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Acta Haematologica|November 24, 2017
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5)Muna Ghazzawi, Varun Mehra, Marcin Knut, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
Blood|March 16, 2002
Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemiaJyoti Wadhwa, Richard M Szydlo, Jane F Apperley, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Genes, Chromosomes & Cancer|January 22, 2008
The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1Claire Hidalgo-Curtis, Andrew Chase, Milton Drachenberg, et al.
Haematologica|April 28, 2010
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasmsThomas Ernst, Andrew Chase, Katerina Zoi, et al.
Leukemia|April 24, 2020
Mutational mechanisms of EZH2 inactivation in myeloid neoplasmsAndrew Chase, Joannah Score, Feng Lin, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Acta Haematologica|November 24, 2017
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5)Muna Ghazzawi, Varun Mehra, Marcin Knut, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
Blood|March 16, 2002
Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemiaJyoti Wadhwa, Richard M Szydlo, Jane F Apperley, et al.
British Journal of Haematology|January 21, 2010
Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsClaire Hidalgo-Curtis, Jane F Apperley, Allistair Stark, et al.
Genes, Chromosomes & Cancer|January 22, 2008
The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1Claire Hidalgo-Curtis, Andrew Chase, Milton Drachenberg, et al.
Haematologica|April 28, 2010
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasmsThomas Ernst, Andrew Chase, Katerina Zoi, et al.
Leukemia|April 24, 2020
Mutational mechanisms of EZH2 inactivation in myeloid neoplasmsAndrew Chase, Joannah Score, Feng Lin, et al.
Pageof 4